University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

University of Alabama at Birmingham Cancer Center is a clinical research site located in Birmingham, Alabama, United States 35233.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham Cancer Center has participated in 347 clinical trials with 194 currently active.

Therapeutic areas: Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma.

Sponsors: National Cancer Institute (NCI), Gynecologic Oncology Group, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham Cancer Center?

University of Alabama at Birmingham Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham Cancer Center conducted?

University of Alabama at Birmingham Cancer Center has 347 clinical trials on record, with 194 currently active. Their work covers Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma.

Is University of Alabama at Birmingham Cancer Center accredited by Crixeo Health?

University of Alabama at Birmingham Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.